Low high-density lipoprotein-cholesterol (HDL-c) is the most remarkable lipid trait both in mild-to-moderate chronic kidney disease (CKD) patients as well as in advanced renal disease stages, and we have previously shown that reduced lecithin:cholesterol acyltransferase (LCAT) concentration is a major determinant of the low HDL phenotype. In the present study, we test the hypothesis that reduced LCAT concentration in CKD contributes to the progression of renal damage. The study includes two cohorts of subjects selected from the PLIC study: a cohort of 164 patients with CKD (NefroPLIC cohort) and a cohort of 164 subjects selected from the PLIC participants with a basal estimated glomerular filtration rate (eGFR) > 60 mL/min/1.73 m2 (PLIC cohort). When the NefroPLIC patients were categorized according to the LCAT concentration, patients in the 1st tertile showed the highest event rate at follow-up with an event hazard ratio significantly higher compared to the 3rd LCAT tertile. Moreover, in the PLIC cohort, subjects in the 1st LCAT tertile showed a significantly faster impairment of kidney function compared to subjects in the 3rd LCAT tertile. Serum from subjects in the 1st LCAT tertile promoted a higher reactive oxygen species (ROS) production in renal cells compared to serum from subjects in the third LCAT tertile, and this effect was contrasted by pre-incubation with recombinant human LCAT (rhLCAT). The present study shows that reduced plasma LCAT concentration predicts CKD progression over time in patients with renal dysfunction, and, even more striking, it predicts the impairment of kidney function in the general population.
Low Plasma Lecithin : Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease / A. Baragetti, A. Ossoli, A. Strazzella, S. Simonelli, I. Baragetti, L. Grigore, F. Pellegatta, A. Catapano, G. Norata, L. Calabresi. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9(2020 Jul 18), pp. 2289.1-2289.13.
|Titolo:||Low Plasma Lecithin : Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease|
BARAGETTI, ANDREA (Primo)
CATAPANO, ALBERICO LUIGI (Corresponding)
NORATA, GIUSEPPE DANILO (Corresponding)
CALABRESI, LAURA (Ultimo) (Corresponding)
|Parole Chiave:||chronic kidney disease; high-density lipoproteins; lecithin:cholesterol acyltransferase|
|Settore Scientifico Disciplinare:||Settore BIO/14 - Farmacologia|
Settore MED/09 - Medicina Interna
|Data di pubblicazione:||18-lug-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/jcm9072289|
|Appare nelle tipologie:||01 - Articolo su periodico|